Crissman J D, Budhraja M, Aron B S, Cummings G
Department of Pathology, Wayne State University, Detroit, Michigan.
Int J Gynecol Pathol. 1987;6(2):97-103. doi: 10.1097/00004347-198706000-00001.
Pretreatment biopsies in 54 patients with Stage II and 37 patients with Stage III squamous cell carcinoma of the uterine cervix were reviewed. The patients were all diagnosed, staged, and treated in a uniform manner in a single radiation therapy unit. The biopsies were scored for degree of keratinization, nuclear pleomorphism, frequency of mitoses, cell size, inflammation, desmoplastic pattern of invasion, and presence or absence of vascular infiltration by tumor. Regression analysis and comparative survivals were analyzed to identify histologic parameters of prognostic value. The 5-year survivals were 60 and 32% for Stage II and III tumors, respectively. None of the histologic parameters evaluated was found to predict patient survival. Subclassification of the tumors by World Health Organization grading criteria also failed to predict patient survival. Stage of disease was the only factor that correlated with patient outcome.
对54例II期和37例III期子宫颈鳞状细胞癌患者的预处理活检进行了回顾。这些患者均在单一放疗单位以统一方式进行诊断、分期和治疗。对活检标本进行角化程度、核多形性、有丝分裂频率、细胞大小、炎症、浸润性促纤维组织增生模式以及肿瘤血管浸润情况评分。进行回归分析和比较生存率分析以确定具有预后价值的组织学参数。II期和III期肿瘤的5年生存率分别为60%和32%。未发现所评估的任何组织学参数能够预测患者生存情况。按照世界卫生组织分级标准对肿瘤进行亚分类也未能预测患者生存情况。疾病分期是与患者预后相关的唯一因素。